Laevolac

Lactulose, the active ingredient in Laevolac, is an osmotic laxative presented as a liquid for oral use. It works by drawing water into the colon to soften stools and by reducing ammonia absorption, making it useful for managing constipation and hepatic encephalopathy in both adult and pediatric patients under medical supervision.

GNH USA supplies Laevolac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for this essential laxative and supporting patient care across diverse healthcare settings.

Laevolac (lactulose) is used as an osmotic laxative to manage conditions related to impaired bowel transit and elevated blood ammonia.

Constipation: softens stool and promotes regular bowel movements. Hepatic encephalopathy: lowers intestinal ammonia production, helping to improve mental status.

Lactulose may cause gastrointestinal and metabolic reactions, most of which are mild and transient.

Common Side Effects: - Flatulence: increased gas production in the colon. - Abdominal cramping: mild to moderate discomfort. - Diarrhea: loose stools, especially at higher doses. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Electrolyte imbalance: severe diarrhea may lead to low potassium or sodium. - Dehydration: excessive fluid loss causing dizziness or low blood pressure. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

When prescribing lactulose, clinicians should consider several safety measures to minimize risk. - Assess renal function: monitor in patients with kidney disease due to risk of electrolyte disturbances. - Evaluate hepatic status: use cautiously in severe liver failure. - Monitor fluid balance: ensure adequate hydration to prevent dehydration. - Adjust dose in pediatric patients: start with lower volume as directed by a pediatrician. - Avoid abrupt discontinuation: taper if long‑term use to prevent rebound constipation. - Store at ambient temperature: keep below 25 °C, in original container, protected from moisture and light.

Lactulose can interact with certain medications and substances, affecting their absorption or efficacy.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: may reduce lactulose efficacy by binding in the gut. - Oral antibiotics: may alter colonic flora, decreasing lactulose conversion and effectiveness.

Moderate Interactions (Monitor Closely): - Diuretics: increased risk of electrolyte imbalance when combined with lactulose‑induced diarrhea. - Metformin: potential for additive gastrointestinal upset. - Phosphate binders: may interfere with lactulose’s osmotic action.